Several pathology studies using surgical specimens from cancer patients have indicated that upregulated levels of CB1 or CB2 were associated with reduced survival and increased tumor metastasis and recurrence (Hashemi et al., 2020; Klein Nulent et al., 2013; Larrinaga et al., 2013; Wu et al., 2012). This evidence concerns the gene CNR2 and cancer.